Relay-Version: version B 2.10 5/3/83; site utzoo.UUCP
Posting-Version: version B 2.10.1 6/24/83; site ttidcb.UUCP
Path: utzoo!decvax!linus!philabs!ttidca!ttidcb!speaker
From: speaker@ttidcb.UUCP (Kenneth Speaker)
Newsgroups: net.med
Subject: Viricide tissues
Message-ID: <559@ttidcb.UUCP>
Date: Mon, 2-Dec-85 18:04:07 EST
Article-I.D.: ttidcb.559
Posted: Mon Dec  2 18:04:07 1985
Date-Received: Wed, 4-Dec-85 20:18:01 EST
Reply-To: speaker@ttidcb.UUCP (Kenneth Speaker)
Distribution: na
Organization: Transaction Technology, Inc. (CitiCorp), Santa Monica
Lines: 15


A recent discussion concerned the use of viricide impregnated tissues to
slow the spread of rhinoviri.  The postings indicated that the tissues
contained ascorbic acid.  I today ran across an article which discussed
the original experiment using iodine impregnated tissues, and then discussed
the current clinical trial using tissues impregnated with a combination
of citric and malic acids, NOT ascorbic acid.

FYI.

It also mentioned that rhinoviri were cultured from 30% of the hands or noses
in the control group, but only 5% in the group using the tissues.

--Kne